Press Releases about Bristol-Myers Squibb
Navigating Interest Rate Speculations and M&A Trends with a Spotlight on Actinium Pharmaceuticals (ATNM)
April 18, 2024
Via AB Newswire
Topics
Economy
Exposures
Interest Rates
From Bristol Myers Squibb
Via Business Wire
Actinium Pharmaceuticals (ATNM): A Prime Buyout Candidate Amidst a Radiopharma Acquisition Wave
March 26, 2024
Via AB Newswire
Topics
Intellectual Property
Exposures
Intellectual Property
From Bristol Myers Squibb
Via Business Wire
Bristol Myers Squibb Announces Expiration of RayzeBio Tender Offer
February 23, 2024
From Bristol Myers Squibb
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|